Persistent lung inflammation after clinical resolution of community-acquired pneumonia as measured by 18FDG-PET/CT.

[1]  M. Fine,et al.  Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America , 2019, American journal of respiratory and critical care medicine.

[2]  P. Gibbs,et al.  Pre-Therapeutic Total Lesion Glycolysis on [18F]FDG-PET Enables Prognostication of 2-Year Progression-Free Survival in MALT Lymphoma Patients Treated with CD20-Antibody-Based Immunotherapy , 2019, Molecular Imaging and Biology.

[3]  J. Song,et al.  Disease Burden and Etiologic Distribution of Community-Acquired Pneumonia in Adults: Evolving Epidemiology in the Era of Pneumococcal Conjugate Vaccines , 2018, Infection & chemotherapy.

[4]  P. Lourenço,et al.  Is there a C-reactive protein value beyond which one should consider infection as the cause of acute heart failure? , 2018, BMC Cardiovascular Disorders.

[5]  R. Harper,et al.  Canakinumab for Atherosclerotic Disease. , 2018, The New England journal of medicine.

[6]  S. Avdeev,et al.  Diagnosis on community-acquired pneumonia (CAP) in patients with congestive heart failure (CHF) , 2017 .

[7]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[8]  Richard Hotchkiss,et al.  A guiding map for inflammation , 2017, Nature Immunology.

[9]  R. Kronmal,et al.  Intermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults. , 2015, American heart journal.

[10]  A. Scarsbrook,et al.  FDG PET/CT in infection and inflammation--current and emerging clinical applications. , 2015, Clinical radiology.

[11]  R. Kronmal,et al.  Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. , 2015, JAMA.

[12]  D. Angus,et al.  Bidirectional relationship between cognitive function and pneumonia. , 2013, American journal of respiratory and critical care medicine.

[13]  K. Langa,et al.  Functional disability, cognitive impairment, and depression after hospitalization for pneumonia. , 2013, The American journal of medicine.

[14]  L. Fried,et al.  Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[15]  T. Vyse,et al.  C-reactive protein in rheumatology: biology and genetics , 2011, Nature Reviews Rheumatology.

[16]  C. Brightling,et al.  Procalcitonin and C-Reactive Protein in Hospitalized Adult Patients With Community-Acquired Pneumonia or Exacerbation of Asthma or COPD , 2010, Chest.

[17]  T. File,et al.  Burden of Community-Acquired Pneumonia in North American Adults , 2010, Postgraduate medicine.

[18]  A. Steinvil,et al.  C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia. , 2009, European journal of internal medicine.

[19]  D. Angus,et al.  Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. , 2008, American journal of respiratory and critical care medicine.

[20]  M. Prokop,et al.  Patterns of resolution of chest radiograph abnormalities in adults hospitalized with severe community-acquired pneumonia. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  R. Holman,et al.  Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. , 2005, JAMA.

[23]  A. E. El Solh,et al.  Radiographic Resolution of Community‐Acquired Bacterial Pneumonia in the Elderly , 2004, Journal of the American Geriatrics Society.

[24]  M. Fine,et al.  Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  John L. Humm,et al.  Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis. , 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[26]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[27]  Inger,et al.  A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.

[28]  S. Young,et al.  Metabolic Activity of the Lung* , 1977, International anesthesiology clinics.

[29]  S. Jay,et al.  The radiographic resolution of Streptococcus pneumoniae pneumonia. , 1975, The New England journal of medicine.

[30]  G. Fanelli,et al.  C-reactive protein (CRP) measurement in geriatric patients hospitalized for acute infection. , 2017, European journal of internal medicine.

[31]  V. Falcó Ferrer,et al.  [Streptococcus pneumoniae pneumonia]. , 1990, Anales de medicina interna.